252 related articles for article (PubMed ID: 22467057)
21. Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.
Zhang W; Yan H
Exp Eye Res; 2012 Dec; 105():1-8. PubMed ID: 23059402
[TBL] [Abstract][Full Text] [Related]
22. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.
Yan J; Tie G; Park B; Yan Y; Nowicki PT; Messina LM
J Vasc Surg; 2009 Dec; 50(6):1412-22. PubMed ID: 19837544
[TBL] [Abstract][Full Text] [Related]
23. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
[TBL] [Abstract][Full Text] [Related]
24. Simvastatin pretreatment enhances ischemia-induced neovascularization and blood flow recovery in streptozotocin-treated mice.
Huang PH; Chen JY; Chen CY; Chen JW; Lin SJ; Shih CC
J Vasc Surg; 2016 Oct; 64(4):1112-1120.e1. PubMed ID: 26830691
[TBL] [Abstract][Full Text] [Related]
25. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis.
Sbaa E; Dewever J; Martinive P; Bouzin C; Frérart F; Balligand JL; Dessy C; Feron O
Circ Res; 2006 May; 98(9):1219-27. PubMed ID: 16601228
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease.
Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T
Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991
[TBL] [Abstract][Full Text] [Related]
27. Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow.
Gertz K; Priller J; Kronenberg G; Fink KB; Winter B; Schröck H; Ji S; Milosevic M; Harms C; Böhm M; Dirnagl U; Laufs U; Endres M
Circ Res; 2006 Nov; 99(10):1132-40. PubMed ID: 17038638
[TBL] [Abstract][Full Text] [Related]
28. Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration.
Kwon SM; Suzuki T; Kawamoto A; Ii M; Eguchi M; Akimaru H; Wada M; Matsumoto T; Masuda H; Nakagawa Y; Nishimura H; Kawai K; Takaki S; Asahara T
Circ Res; 2009 Apr; 104(8):969-77. PubMed ID: 19325148
[TBL] [Abstract][Full Text] [Related]
29. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
[TBL] [Abstract][Full Text] [Related]
30. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue.
Duan H; Cheng L; Sun X; Wu Y; Hu L; Wang J; Zhao H; Lu G
Thromb Haemost; 2006 Dec; 96(6):807-15. PubMed ID: 17139377
[TBL] [Abstract][Full Text] [Related]
31. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
Ii M; Nishimura H; Iwakura A; Wecker A; Eaton E; Asahara T; Losordo DW
Circulation; 2005 Mar; 111(9):1114-20. PubMed ID: 15723985
[TBL] [Abstract][Full Text] [Related]
32. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.
Takahashi T; Kalka C; Masuda H; Chen D; Silver M; Kearney M; Magner M; Isner JM; Asahara T
Nat Med; 1999 Apr; 5(4):434-8. PubMed ID: 10202935
[TBL] [Abstract][Full Text] [Related]
33. NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes.
Ebrahimian TG; Heymes C; You D; Blanc-Brude O; Mees B; Waeckel L; Duriez M; Vilar J; Brandes RP; Levy BI; Shah AM; Silvestre JS
Am J Pathol; 2006 Aug; 169(2):719-28. PubMed ID: 16877369
[TBL] [Abstract][Full Text] [Related]
34. Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells.
Barthelmes D; Irhimeh MR; Gillies MC; Karimipour M; Zhou M; Zhu L; Shen WY
Blood Cells Mol Dis; 2013 Oct; 51(3):163-73. PubMed ID: 23714230
[TBL] [Abstract][Full Text] [Related]
35. Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing.
Kim JY; Song SH; Kim KL; Ko JJ; Im JE; Yie SW; Ahn YK; Kim DK; Suh W
Cell Transplant; 2010; 19(12):1635-44. PubMed ID: 20659357
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.
Hamada H; Kim MK; Iwakura A; Ii M; Thorne T; Qin G; Asai J; Tsutsumi Y; Sekiguchi H; Silver M; Wecker A; Bord E; Zhu Y; Kishore R; Losordo DW
Circulation; 2006 Nov; 114(21):2261-70. PubMed ID: 17088460
[TBL] [Abstract][Full Text] [Related]
37. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy.
Sorrentino SA; Besler C; Rohrer L; Meyer M; Heinrich K; Bahlmann FH; Mueller M; Horváth T; Doerries C; Heinemann M; Flemmer S; Markowski A; Manes C; Bahr MJ; Haller H; von Eckardstein A; Drexler H; Landmesser U
Circulation; 2010 Jan; 121(1):110-22. PubMed ID: 20026785
[TBL] [Abstract][Full Text] [Related]
38. Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide.
Goldstein LJ; Gallagher KA; Bauer SM; Bauer RJ; Baireddy V; Liu ZJ; Buerk DG; Thom SR; Velazquez OC
Stem Cells; 2006 Oct; 24(10):2309-18. PubMed ID: 16794267
[TBL] [Abstract][Full Text] [Related]
39. Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type-1 diabetic mice.
Emanueli C; Monopoli A; Kraenkel N; Meloni M; Gadau S; Campesi I; Ongini E; Madeddu P
Br J Pharmacol; 2007 Apr; 150(7):873-82. PubMed ID: 17351667
[TBL] [Abstract][Full Text] [Related]
40. In vivo enhancement of angiogenesis by adenoviral transfer of HIF-1alpha-modified endothelial progenitor cells (Ad-HIF-1alpha-modified EPC for angiogenesis).
Jiang M; Wang B; Wang C; He B; Fan H; Shao Q; Gao L; Liu Y; Yan G; Pu J
Int J Biochem Cell Biol; 2008; 40(10):2284-95. PubMed ID: 18450499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
